United States Blockchain in Pharma Supply Chain Management Market 2025 | Industry Insights, Share, Future Growth, Industry Scope, FDA Approvals | Major Players are Cloud Software Group, Inc., Auxesis Infotech Pvt. Ltd., Omnichain Solutions, Walmart Inc.,

blockchain in pharmaceutical supply chain management market reached US$ 1.27 billion in 2024 and is expected to reach US$ 6.57 billion by 2033, growing at a CAGR of 21.5% during the forecast period 2025-2033

DataM Intelligence has published a new research report on "Blockchain in Pharmaceutical Supply Chain Management Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/blockchain-in-pharmaceutical-supply-chain-management-market?kb

Latest M&A Activity

M&A activity is moderate, with large cloud and technology providers like IBM, Microsoft, and AWS acquiring smaller specialized blockchain firms focused on pharma supply chain traceability and anti-counterfeiting solutions.

Companies such as Chronicled and FarmaTrust, offering niche blockchain platforms for drug traceability and security, have been key acquisition targets as pharma giants seek to expand capabilities in secure supply chain management.

Key Players:

IBM, Microsoft, SAP SE, Oracle, Cloud Software Group, Inc., Auxesis Infotech Pvt. Ltd., Omnichain Solutions, Walmart Inc., FarmaTrust, Amazon Web Services, Inc.

Key Development:

In November 2024, Ethiopia's Food and Drug Authority (EFDA) partnered with Medical Value Chain to implement a blockchain-enabled pharmaceutical track-and-trace system to combat counterfeit drugs.

Healthcare data breaches continue to rise. In 2023, over 540 organizations and 112 million individuals were affected, up from 590 organizations and 48.6 million individuals in 2022, with multiple breaches impacting over 500,000 records. Blockchain is increasingly used to enhance data security.

According to the Pharmaceutical Security Institute (PSI), 6,897 incidents of pharmaceutical counterfeiting, theft, and illegal diversion occurred across 142 countries in 2023, involving 2,440 medicines, with 4,894 arrests-the highest in 22 years.

The World Health Organization estimates that 1 in 10 medicines in low- and middle-income countries are substandard or falsified, costing around US$30.5 billion annually. The NIH estimates up to 15% of drugs sold are fake, exceeding 50% in parts of Africa and Asia; the FDA notes fake drugs account for roughly 10% of the global market.

Recent blockchain-based drug traceability solutions include Merck's May 2024 launch of M-Trace Software & Mobile App for digitizing sterility testing.

Cyberattacks on healthcare have surged, with large breaches increasing 93% and ransomware-related breaches rising 278% from 2018 to 2023 (Palo Alto Networks, Jan 2024).

The FDA issued alerts in January 2024 for counterfeit Botox and, in December 2023, for fake Ozempic injections, reinforcing North America's market dominance.

In September 2023, Mauritius launched a blockchain-based eVerify system to authenticate information electronically. Emerging technologies like blockchain, AI, and big data are transforming consumer interactions and disrupting traditional healthcare models

Growth Forecast Projected:

The Global Blockchain in Pharmaceutical Supply Chain Management Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Blockchain in Pharmaceutical Supply Chain Management Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=blockchain-in-pharmaceutical-supply-chain-management-market?kb

Key Segments:

By Offerings: (Platform, Service)

By Application: (Drug Traceability, Inventory Monitoring, Smart Contracts, Compliance Management, Payment & Settlement, Others)

By Type: (Private Blockchain, Public Blockchain, Hybrid Blockchain)

By End User: (Manufacturers, Distributors, Healthcare Providers)

Latest News and Product Developments

Blockchain implementations have expanded from drug traceability to cold-chain monitoring, smart contracts for automated regulatory compliance, and real-time supply chain visibility.

Firms like Pfizer and IBM are collaborating on blockchain platforms to improve drug authenticity verification and streamline recalls, reducing counterfeit drug risks.

New solutions integrate blockchain with IoT devices like temperature sensors and RFID/QR tagging to ensure quality during transport, especially for vaccines and biologics.

India's National Blockchain Framework launched recently supports blockchain adoption across sectors, including pharmaceuticals, enabling secure document management and supply chain data transparency.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

FDA Approvals and Regulatory Affairs

Although blockchain itself is not FDA-approved as a product, the FDA encourages innovations that enhance traceability and data integrity, such as blockchain-based pilots under the Drug Supply Chain Security Act (DSCSA).

Blockchain enables immutable recordkeeping and audit trails that comply with FDA standards including 21 CFR Part 11 for electronic records, supporting quality system regulations.

Globally, regulatory bodies are showing cautious support, seeing blockchain as a tool to ensure compliance with traceability laws like the EU's Falsified Medicines Directive and WHO standards.

Using blockchain helps pharma companies meet data privacy laws (HIPAA, GDPR) by controlling data access on permissioned networks

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/blockchain-in-pharmaceutical-supply-chain-management-market?kb

Reimbursement and Quality Assurance

Blockchain facilitates quality assurance by creating tamper-proof product histories accessible to manufacturers, regulators, healthcare providers, and even patients, enhancing trust and patient safety.

The technology's smart contracts automate compliance checks, supplier qualification, and batch releases, reducing manual audit efforts and compliance costs.

As reimbursement increasingly ties to product quality and traceability in pharma supply chains (especially in biologics and specialty drugs), blockchain's role in providing verifiable data chains becomes critical.

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/blockchain-in-pharmaceutical-supply-chain-management-market?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.